Volume 55, Issue 3, Pages (August 2014)

Slides:



Advertisements
Similar presentations
Volume 41, Issue 5, Pages (November 2014)
Advertisements

Volume 55, Issue 1, Pages (July 2014)
Volume 68, Issue 3, Pages e5 (November 2017)
JNK1 Phosphorylation of Cdt1 Inhibits Recruitment of HBO1 Histone Acetylase and Blocks Replication Licensing in Response to Stress  Benoit Miotto, Kevin.
Volume 38, Issue 4, Pages (May 2010)
Global Mapping of Human RNA-RNA Interactions
Volume 11, Issue 2, Pages (August 2012)
Roger B. Deal, Steven Henikoff  Developmental Cell 
Volume 44, Issue 3, Pages (November 2011)
Volume 54, Issue 1, Pages (April 2014)
SAGA Is a General Cofactor for RNA Polymerase II Transcription
Volume 29, Issue 1, Pages (April 2014)
Volume 19, Issue 3, Pages (April 2017)
N6-Methyladenosines Modulate A-to-I RNA Editing
Volume 63, Issue 2, Pages (July 2016)
Volume 23, Issue 5, Pages (May 2018)
Nucleosome-Driven Transcription Factor Binding and Gene Regulation
The Translational Landscape of the Mammalian Cell Cycle
Volume 17, Issue 4, Pages (October 2015)
Volume 66, Issue 1, Pages e5 (April 2017)
Volume 50, Issue 6, Pages (June 2013)
Volume 43, Issue 5, Pages (September 2011)
Volume 149, Issue 7, Pages (June 2012)
Volume 49, Issue 1, Pages (January 2013)
Volume 10, Issue 6, Pages (June 2018)
Volume 62, Issue 1, Pages (April 2016)
Volume 60, Issue 2, Pages (October 2015)
Volume 56, Issue 5, Pages (December 2014)
Volume 67, Issue 6, Pages e6 (September 2017)
Volume 46, Issue 1, Pages (April 2012)
Volume 42, Issue 6, Pages (June 2011)
Volume 44, Issue 3, Pages (November 2011)
Volume 62, Issue 1, Pages (April 2016)
Human Promoters Are Intrinsically Directional
Volume 64, Issue 6, Pages (December 2016)
Volume 72, Issue 2, Pages e5 (October 2018)
A Genetic Screen Identifies TCF3/E2A and TRIAP1 as Pathway-Specific Regulators of the Cellular Response to p53 Activation  Zdenek Andrysik, Jihye Kim,
Spatial and Temporal Recruitment of Androgen Receptor and Its Coactivators Involves Chromosomal Looping and Polymerase Tracking  Qianben Wang, Jason S.
Volume 14, Issue 6, Pages (June 2014)
Volume 51, Issue 5, Pages (September 2013)
Volume 10, Issue 10, Pages (October 2017)
An RNAi Screen of Chromatin Proteins Identifies Tip60-p400 as a Regulator of Embryonic Stem Cell Identity  Thomas G. Fazzio, Jason T. Huff, Barbara Panning 
Volume 14, Issue 5, Pages (February 2016)
Volume 13, Issue 1, Pages (October 2015)
Volume 122, Issue 6, Pages (September 2005)
Volume 66, Issue 4, Pages e4 (May 2017)
Xudong Wu, Jens Vilstrup Johansen, Kristian Helin  Molecular Cell 
Polycomb Protein Ezh1 Promotes RNA Polymerase II Elongation
Volume 14, Issue 6, Pages (June 2014)
Volume 156, Issue 4, Pages (February 2014)
Volume 42, Issue 6, Pages (June 2011)
Volume 63, Issue 3, Pages (August 2016)
Gene Density, Transcription, and Insulators Contribute to the Partition of the Drosophila Genome into Physical Domains  Chunhui Hou, Li Li, Zhaohui S.
Volume 7, Issue 2, Pages (August 2010)
Volume 9, Issue 3, Pages (November 2014)
Functional Landscape of PCGF Proteins Reveals Both RING1A/B-Dependent-and RING1A/B-Independent-Specific Activities  Andrea Scelfo, Daniel Fernández-Pérez,
Anne Pfeiffer, Hui Shi, James M. Tepperman, Yu Zhang, Peter H. Quail 
Amanda O'Donnell, Shen-Hsi Yang, Andrew D. Sharrocks  Molecular Cell 
Volume 56, Issue 6, Pages (December 2014)
Short Telomeres in ESCs Lead to Unstable Differentiation
Volume 17, Issue 3, Pages (October 2016)
Volume 12, Issue 8, Pages (August 2015)
Volume 41, Issue 2, Pages (January 2011)
Volume 8, Issue 1, Pages (July 2014)
Volume 9, Issue 3, Pages (November 2014)
Volume 55, Issue 1, Pages (July 2014)
Volume 14, Issue 6, Pages (February 2016)
Volume 26, Issue 11, Pages e3 (March 2019)
Lack of Transcription Triggers H3K27me3 Accumulation in the Gene Body
Volume 21, Issue 4, Pages (February 2006)
Presentation transcript:

Volume 55, Issue 3, Pages 347-360 (August 2014) Gene Silencing Triggers Polycomb Repressive Complex 2 Recruitment to CpG Islands Genome Wide  Eva Madi Riising, Itys Comet, Benjamin Leblanc, Xudong Wu, Jens Vilstrup Johansen, Kristian Helin  Molecular Cell  Volume 55, Issue 3, Pages 347-360 (August 2014) DOI: 10.1016/j.molcel.2014.06.005 Copyright © 2014 Elsevier Inc. Terms and Conditions

Molecular Cell 2014 55, 347-360DOI: (10.1016/j.molcel.2014.06.005) Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 1 PRC2 Is Not Required for Gene Expression Homeostasis in mESCs (A) Categorization of expression changes for either all genes or PRC2 target genes upon KO of different PcG genes in mESCs grown in 2i conditions. (B) Distributions of log2 ratio of gene expression. Same data sets are analyzed here and in (A1)–(A4). (C) Expression fold changes of 12 different PRC2 target genes analyzed by RT-qPCR upon either transient KD or permanent KO of different PcG genes in mESCs grown in serum conditions. Black segments indicate median values. Statistical significances between WT and PcG-depleted cells (Student’s t test) are indicated. See also Figure S1 and Table S1. Molecular Cell 2014 55, 347-360DOI: (10.1016/j.molcel.2014.06.005) Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 2 PRC2 Is Not Required for Gene Expression Changes during Differentiation of mESCs but Is Required for Their Maintenance (A) Gene expression in WT and Suz12−/− mESCs during 3 days of differentiation. Expression levels are indicated as log10 of reads per kilobases per million mapped reads (RPKM). The top graph shows expression distributions for either all genes or changing genes only, together with the colors scale used for the heatmap. Heatmap columns correspond to differentiation time points for each genotype, and a hierarchical clustering of these eight conditions is indicated above. Heatmap rows correspond to genes detected in at least one condition, and their expression change category (i.e., 0 hr versus 72 hr) is annotated on the right. Grey segments on the left and right of the heatmap indicate genes that are Suz12 targets at 0 hr only and 72 hr only, respectively. (B) Categorization of expression changes for either all genes or PRC2 target genes upon Suz12 KO in mESCs grown in serum conditions or after 72 hr of differentiation. (C) Time course analysis of the expression fold change of genes that are de novo PRC2 targets after 72 hr of differentiation. This analysis was performed on genes categorized as downregulated (i.e., 0 hr versus 72 hr) in WT or Suz12−/− cells and Suz12 targets at 72 hr only (top panel), and on a control population of genes (bottom panel). Boxes indicate the median value, 2nd and 3rd quartiles of the percentage distribution. Whiskers indicate 10th and 90th percentiles. (D) Time course analysis by RT-qPCR of the effect of Suz12 KO on the expression of three genes that become PRC2 targets during long-term differentiation in embryoid body (EB) formation assays. Data are represented as mean ±SD. See also Figure S2 and Tables S2 and S3. Molecular Cell 2014 55, 347-360DOI: (10.1016/j.molcel.2014.06.005) Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 3 Inhibition of Transcription Leads to De novo PRC2 Recruitment Genome Wide (A) Western blot analysis of the effect of DRB or Triptolide on RNAPII and PRC2, using antibodies against all forms of RNAPII (N-20) and RNAPII phosphorylated at serine 2 (Ser2-P) or at serine 5 (Ser5-P), Suz12, H3K27me3, and Vinculin as loading control. The phosphorylated form of RNAPII is indicated by an asterisk. (B) Time course analysis of the effect of DRB and Triptolide on transcription by RT-qPCR analysis of unspliced RNA for four genes expressed in mESCs. Data are represented as mean ±SD. (C) Time course analysis of the effect of DRB and Triptolide on PRC2 recruitment by ChIP-qPCR analysis of Suz12 binding on three promoters that are not PcG targets in mESCs. IgG is used as negative control for ChIP. Data are represented as mean ±SD. (D) Example of tracks (Mycn locus) from ChIP-seq analysis of the effect of DRB and Triptolide on Suz12, H3K27me3, and RNAPII binding. Enrichment levels are expressed in read per million mapped reads (RPM). Genome scale, release and annotations are indicated. (E) Number of distinct and overlapping Suz12 peaks before and after inhibition of transcription. See also Figure S3. Molecular Cell 2014 55, 347-360DOI: (10.1016/j.molcel.2014.06.005) Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 4 Drug-Induced Suz12 Binding in mESCs Occurs at the CGIs of Genes that Are PRC2 Targets in Differentiated Tissues (A and B) Percentage of endogenous (orange) or drug-induced Suz12 peaks after either 12 hr DRB (blue) or 9 hr Triptolide (green) treatment that overlap with genes (A) or CGIs (B). (C) Percentage of drug-induced Suz12 target genes in mESCs that are endogenous PRC2 targets in other mouse tissues (see Supplemental Experimental Procedures). (D) Relative contribution of each tissue represented in the mouse PRC2 target database in the identification of drug-induced target genes. (E) Time course analysis of Suz12 binding and H3K27me3 deposition fold changes on nontarget CGIs (top panels) and over control regions (bottom panels) during either DRB or Triptolide treatment. Boxplots are formatted as in Figure 2C. Data are represented as mean ±SD. See also Table S4. Molecular Cell 2014 55, 347-360DOI: (10.1016/j.molcel.2014.06.005) Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 5 Transcription Regulates PRC2 Recruitment to Target Genes (A) A 4kb element from the CGI-containing c-Jun promoter was integrated upstream of a luciferase reporter (luc+) in an engineered FRT mESC line (Figures S4A and S4B). Position of insert-specific primers for ChIP-qPCR analysis is indicated in red. (B) Luciferase assay and RT-qPCR analysis of the expression of the c-Jun gene or the luciferase reporter driven by the 4 kb c-Jun element, before (ESC) and after (Diff.) differentiation. Luciferase counts were normalized to total protein amount. (C) ChIP-qPCR analysis of Suz12 binding on both endogenous c-Jun promoter and transgenic 4 kb element before (E) and after (D) 72 hr of differentiation. (D) The 4kb c-Jun element was replaced by a 500 bp subfragment lacking the TSS, at the same genomic insertion site (Figure S4B). (E) Luciferase assay and RT-qPCR analysis as in (B) but with the 500 bp c-Jun element. (F) ChIP-qPCR analysis as in (C) but on integrated 500 bp c-Jun element. (G) The mPGK promoter was inserted upstream of the transgene either lacking (top) or containing (bottom) the 500 bp c-Jun element. Position of mPGK-specific primers for ChIP-qPCR analysis is indicated in red. (H) Luciferase assay with both construct variants presented in (G). Values correspond to the average from seven to eight stable clones for each construct. (I) ChIP-qPCR on the PGK-c-Jun construct. (J) ChIP-qPCR as in (I) but either before or after 7 hr of Triptolide treatment. All FRT cell lines were grown under 2i conditions and induced to differentiate as described in Supplemental Experimental Procedures. See also Figure S4. Molecular Cell 2014 55, 347-360DOI: (10.1016/j.molcel.2014.06.005) Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 6 Most CGIs Are either Transcribed or Enriched for PRC2 (A) Setup of transcription inhibition time course analysis by iTC-seq upon DRB or Triptolide treatment of WT mESCs. Sampling time points are indicated on the time line. (B) Example of tracks (Fgf4 locus) from iTC-seq time course analysis. Negative values, due to background subtraction, are plotted in gray. (C) Comparative analysis of Suz12 binding on CGIs and transcription of their overlapping genes. Each parameter was segmented in low and high levels (i.e., 200 RPK for Suz12 binding and 2 RPK for transcription). Inserts show magnifications of the lower values. (D) Distribution of CGIs present in the four categories defined in (C). See also Figure S5. Molecular Cell 2014 55, 347-360DOI: (10.1016/j.molcel.2014.06.005) Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 7 PRC2 Is Recruited to Nucleosome Free CGIs (A) CGI category changes upon drug treatments. Heatmap rows correspond to CGIs and columns to cell treatments. (B) Relation between CGIs category changes upon drug treatment and CGI nucleosome content in untreated mESCs. Color code refers to Figure 7A. Boxplots are formatted as in Figure 2C. Statistical significances between tested classes (Student’s t test) are indicated. (C) Average profiles of nucleosome occupancy (in untreated cells) and Suz12 binding on PRC2 target CGIs before and after drug treatments in mESCs. See also Figure S6. Molecular Cell 2014 55, 347-360DOI: (10.1016/j.molcel.2014.06.005) Copyright © 2014 Elsevier Inc. Terms and Conditions